Riskpilot← Back to searchSign inGet full accessOphtadoc AB
ABActiveOrg 5590513841Blåsippevägen 9Medical specialists activities · NACE 8622Est. 20161 employees
Revenue 2025
SEK 7,3M
-1% vs 2024
EBITDA margin
72.2%
+147% vs 2024
Equity ratio
54.9%
Financial strength
Net profit 2025
SEK 3,6M
+138% vs 2024
| Revenue | SEK 7,3M | -1% |
| EBITDA | SEK 5,2M | +147% |
| Net profit | SEK 3,6M | +138% |
| Total assets | SEK 12,4M | +31% |
| Equity | SEK 6,8M | +37% |
| Employees | 1 | — |
Legal name
Ophtadoc AB
Org number
5590513841
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 februari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva ögonsjukvård, kirurgi inom oftalmologi inklusive refraktiv kirurgi, medicinsk estetisk verksamhet, personaluthyrning inom sjukvård, utbildning och konsultationsverksamhet inom oftalmologi, förvaltning av värdepapper och fastigheter samt därmed förenlig verksamhet
Address
Blåsippevägen 9
Email
johge950@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 706 | 4 154 | 5 335 | 7 331 | 7 252 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 557 | 1 996 | 3 173 | 2 115 | 5 234 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 557 | 1 996 | 3 173 | 2 115 | 5 234 |
| Net financials | −1 | 356 | 34 | −20 | 429 |
| Profit before tax | 1 165 | 1 890 | 2 560 | 1 920 | 4 494 |
| Tax | −243 | −369 | −544 | −426 | −936 |
| Net profit | 922 | 1 521 | 2 016 | 1 494 | 3 558 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 473 | 5 967 | 8 381 | 9 458 | 12 395 |
| Equity | 1 937 | 2 793 | 4 145 | 4 973 | 6 799 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 555 | 729 | 1 144 | 1 218 | 1 160 |
| Total debt | 555 | 729 | 1 144 | 1 218 | 1 160 |
EBITDA margin
72.2%
This company
15.8%
Market median
+357% vs market
20212025
Equity ratio
54.9%
This company
38.2%
Market median
+44% vs market
20212025
Return on equity
52.3%
This company
18.4%
Market median
+184% vs market
20212025
Net profit margin
49.1%
This company
8.1%
Market median
+506% vs market
20212025
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20212025
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ophtadoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Sigfrid Germundsson | Deputy Board Member | 0 companies |
| Johan Rudolf Germundsson | Board of Directors | 0 companies |
| Anna Maria Germundsson | Deputy Board Member | 0 companies |